Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


We're sorry, that page (http://www.bio-medicine.org/medicine-technology-1/mjffs-rapid-response-innovation-awards-hit-mid-2009-with-over--241-million-funded-in-high-risk-high-reward-approaches-to-parkinsons-disease-4652-1/;msg18067;topicseen) was not found.

Search medicine technology 1 mjffs rapid response innovation awards hit mid 2009 with over 241 million funded in high risk high reward approaches to parkinsons disease 4652 1 ;msg18067;topicseen at Google

Search medicine technology 1 mjffs rapid response innovation awards hit mid 2009 with over 241 million funded in high risk high reward approaches to parkinsons disease 4652 1 ;msg18067;topicseen at Yahoo

Search medicine technology 1 mjffs rapid response innovation awards hit mid 2009 with over 241 million funded in high risk high reward approaches to parkinsons disease 4652 1 ;msg18067;topicseen at Msn

Google
 
(Date:11/4/2009)...t Norman has received more than $10 million in res... the federal stimulus program, bringing thetotal a...rs to $23 million. Thirty-three projects achieved...logy to weather. , "The university has thoughtfu...reasof scholarly excellence to federal agency prio...
(Date:11/4/2009)...PRNewswire-FirstCall/ -- Quest Diagnostics Incorpo...of diagnostic testing, information and services, a...r 30, 2009, income from continuing operations rose... $160 million, or $0.81 per diluted share, for the...ults were reduced by a $0.03 per share charge asso...
(Date:11/4/2009)... Aware, Inc. (Nasdaq: AW...nd biometrics software, today reported financial r...2009. ,, Michael Tzannes, Aware,s Chairman an...e announced an agreement to sell our DSL and home ...semiconductor company being spun out of Infineon. ...
Breaking Biology News(10 mins):OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product 13449 1Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product 13449 2Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product 13449 3EGEN Inc Announces the Promotion of Jason Fewell Ph D to Vice President of Preclinical Research and Development 13448 1EGEN Inc Announces the Promotion of Jason Fewell Ph D to Vice President of Preclinical Research and Development 13448 2NeurogesX Reports Second Quarter 2009 Results 13446 1NeurogesX Reports Second Quarter 2009 Results 13446 2NeurogesX Reports Second Quarter 2009 Results 13446 3NeurogesX Reports Second Quarter 2009 Results 13446 4NeurogesX Reports Second Quarter 2009 Results 13446 5NeurogesX Reports Second Quarter 2009 Results 13446 6NeurogesX Reports Second Quarter 2009 Results 13446 7NeurogesX Reports Second Quarter 2009 Results 13446 8NeurogesX Reports Second Quarter 2009 Results 13446 9NeurogesX Reports Second Quarter 2009 Results 13446 10NeurogesX Reports Second Quarter 2009 Results 13446 11NeurogesX Reports Second Quarter 2009 Results 13446 12
(Date:11/9/2009)... SHENZHEN, China, Nov. 9 /PRNewswire-Asia-FirstC...E: MR ), a leading developer, manufacturer and,ma...ay its selected unaudited,financial results for th...,2009. , , Highlights for Operations as of Se...enues were $151.1 million, an increase of, 3...
(Date:11/9/2009)...House action backs President Obama,s promise to no... example ,, Bishops still concerned for poor,...ewswire/ -- Cardinal Francis George of Chicago, pr...c Bishops, lauded the November 7 decision of the U...th care reform money from paying for elective abor...
(Date:11/9/2009)... Studying Genetic Variance Acros...ts of Genes , (Vocus) Nov...estries can be extraordinarily valuable when analy...ti-center genetics study that scanned the genome...r regional differences, Drs. Chao Tian and Michael...
(Date:11/9/2009)... implanted with new cells regained sexual function...lthDay News) -- Researchers were able to restore s...growing new penile tissue in the lab and implantin...lication is a ways off, researchers say the techni... dysfunction in men. , "We were able to show th...
(Date:11/9/2009)... Course, to be Offered in April ...olkit , Cambridge, MA (Vo...ysicians for Human Rights (PHR) first inspected a ...tan , he realized he would need a team of experts ...ing the site properly was a key first step in secu...
Breaking Medicine News(10 mins):Health News:Mindray Announces Third Quarter 2009 Financial Results 2Health News:Mindray Announces Third Quarter 2009 Financial Results 3Health News:Mindray Announces Third Quarter 2009 Financial Results 4Health News:Mindray Announces Third Quarter 2009 Financial Results 5Health News:Mindray Announces Third Quarter 2009 Financial Results 6Health News:Mindray Announces Third Quarter 2009 Financial Results 7Health News:Mindray Announces Third Quarter 2009 Financial Results 8Health News:Mindray Announces Third Quarter 2009 Financial Results 9Health News:Mindray Announces Third Quarter 2009 Financial Results 10Health News:Mindray Announces Third Quarter 2009 Financial Results 11Health News:Mindray Announces Third Quarter 2009 Financial Results 12Health News:Mindray Announces Third Quarter 2009 Financial Results 13Health News:Mindray Announces Third Quarter 2009 Financial Results 14Health News:Mindray Announces Third Quarter 2009 Financial Results 15Health News:Mindray Announces Third Quarter 2009 Financial Results 16Health News:Mindray Announces Third Quarter 2009 Financial Results 17Health News:Mindray Announces Third Quarter 2009 Financial Results 18Health News:Cardinal George Lauds House Action to Ban Federal Funds for Abortion; Promises Vigilance as Senate Pursues Health Care Reform, Wary About Affect on Poor, Elderly 2Health News:Cardinal George Lauds House Action to Ban Federal Funds for Abortion; Promises Vigilance as Senate Pursues Health Care Reform, Wary About Affect on Poor, Elderly 3Health News:News from the November/December Issue of Molecular Medicine 2Health News:Scientists Grow New Penile Tissue in the Lab 2Health News:Scientists Grow New Penile Tissue in the Lab 3Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 2Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 3Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 4
Iscove's Modified Dulbecco's Medium (IMDM) from Sigma-Aldrich
Nutrient Mixture F-12 Ham, Coon's Modification (Ham's F-12 Coon's) from Sigma-Aldrich
...solution is an isotonic, balanced salt solution. I...ervative, which permits the storage of whole blood... weeks.1 For usage, an equal volume of blood is co...y, but thoroughly, mixed. The solution is placed i...
...Mix or individual RNA sequences from high throughp...om small RNAs from LC Sciences. These products pro...ons) of DESIGNED sequences delivered in a microtub...taining a single verified RNA sequence. This is a ...
Biology Products:
Creatine Kinase Reagent
Creatine Kinase-MB (CK-MB)
Magnesium Liquid Reagent
Glucose Oxidase Reagent Set (Phenol Free)
Medicine Products:
(Date:11/9/2009).... 9 NexBio, Inc. announced the pre...College of Allergy, Asthma, and Immunology in Miam... (Fludase®), a Sialidase, Decreases Airway Re...in Animal Models of Asthma". ,, DAS181 (Fludase...t-targeting drug candidate being studied in human ...
(Date:11/9/2009)...vember 9 Following the provision o...Drug Administration (FDA), privately,owned UK comp...international.com ) has been informed that its inn...n awarded an Orphan-Drug,designation for the treat..., ALS, also known as Lou Gehrig,s disease, is ...
(Date:11/6/2009)...6 /PRNewswire-FirstCall/ - Microbix Biosystems Inc...iled the Form 52-109F1 Certification of Annual Fil...r and James Long, the Chief Financial Officer (the...in connection with the annual audited financial st..., The Company initially filed the annual financi...
(Date:11/6/2009)...stria, November 6 EUCODIS Bioscien...ng, and marketing enzymes for the,chemical industr...rch,agreement with Bio Sidus, the leading biopharm... agreement gives EUCODIS Bioscience exclusive acce...o Sidus, proprietary collection of,psychrophilic b...
Breaking Biology Technology:NexBio(R) Presents Data Showing Anti-Asthma Activity of DAS181 (Fludase(R)*) at ACAAI 2009 2NexBio(R) Presents Data Showing Anti-Asthma Activity of DAS181 (Fludase(R)*) at ACAAI 2009 3EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2
(Date:11/9/2009)...PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc...ults from the Company,s Bepreve(TM) (bepotastine b... studies. These results were presented in poster ...n College of Allergy, Asthma & Immunology (ACA...ation titled, "Treatment of Ocular Itching with Be...
(Date:11/9/2009)...., Nov. 9 Thomson Reuters today ... CareFocus, a leading clinical surveillance soluti...ents in real-time and respond immediately to impro...ment. ,, This upgrade is available to current C...CareFocus 2.0 contains several powerful enhancemen...
(Date:11/9/2009)...ov. 9 Arcadia Resources,...novative consumer health care services under the A... Goldsmith to its Board of Directors. Goldsmith w...n from the Board. ,, (Photo: http://www.ne...Goldsmith is the Daniel Paul Professor of Governme...
Breaking Medicine Technology:ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 2ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 3Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 2Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 3Arcadia Resources Names Stephen Goldsmith to Board of Directors 2Arcadia Resources Names Stephen Goldsmith to Board of Directors 3NATB Announces Partnership With Ronald McDonald House Charities 28R 29 53932 1NATB Announces Partnership With Ronald McDonald House Charities 28R 29 53932 2NATB Announces Partnership With Ronald McDonald House Charities 28R 29 53932 3Mother 26 Daughter Celebrate Victory Over Meth 53930 1Mother 26 Daughter Celebrate Victory Over Meth 53930 2American Oriental Bioengineering Reports Second Quarter 2009 Financial Results 13442 1American Oriental Bioengineering Reports Second Quarter 2009 Financial Results 13442 2American Oriental Bioengineering Reports Second Quarter 2009 Financial Results 13442 3American Oriental Bioengineering Reports Second Quarter 2009 Financial Results 13442 4American Oriental Bioengineering Reports Second Quarter 2009 Financial Results 13442 5American Oriental Bioengineering Reports Second Quarter 2009 Financial Results 13442 6American Oriental Bioengineering Reports Second Quarter 2009 Financial Results 13442 7American Oriental Bioengineering Reports Second Quarter 2009 Financial Results 13442 8